Document is current
Any future updates will be listed below
-
Authors
Cypris, Olivia
Franzen, Julia
Frobel, Joana
Glück, Philipp
Kuo, Chao-Chung
Schmitz, Stephani
Nüchtern, Selina
Zenke, Martin
Wagner, Wolfgang https://orcid.org/0000-0002-1971-3217
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (WA 1706/8-1, WA 1706/12-1)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Aachen, Medizinische Fakultät (O3-3)
Deutsche Krebshilfe (TRACK-AML)
Bundesministerium für Bildung und Forschung (VIP+ Epi-Blood-Count)
Else Kröner-Fresenius-Stiftung (ForTra gGmbH für Forschungstransfer)
RWTH Aachen University
- License Information
-
More Information
Article History
Received: 25 February 2022
Accepted: 7 June 2022
First Online: 15 June 2022
Declarations
:
: Mesenchymal stromal cells and KIT+ cells were taken after informed and written consent and the study was approved by the Ethic Committee of the Use of Human Subjects at the University of Aachen (permit numbers: EK128/09 and EK206/09, respectively).
: Not applicable.
: W.W. and P.G. are involved in Cygenia GmbH that can provide service for various epigenetic signatures, including Epi-Pluri-Score analysis (). Apart from this, the authors declare no competing interests.
